Review
Open access
Aug 2026
From Resistance to Renewal: Design Strategies and Structure–Activity Relationships of Novel EGFR Inhibitors in Breast Cancer: Mini Review
New findings on the design of small molecules that inhibit EGFR including pyrimidine‐5‐carbonitrile, thiazolyl‐pyrazolines, quinoxaline, quinazoline–sulfonamide hybrids, xanthine–chalcone conjugates, aminoquinolines, and pyridazine analogues are summarized.
Neelima Shrivastava, C. Ranjan
· ChemistrySelect · 0 citations